3 news items
Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
FENC
14 May 24
, timeline and other goals, plans and prospects, including our commercialization plans respecting PEDMARK®, the market opportunity
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
FENC
17 Mar 24
statements about our business strategy, timeline and other goals, plans and prospects, including our commercialization plans respecting PEDMARK®
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
FENC
29 Feb 24
statements about our business strategy, timeline, and other goals, plans and prospects, including our commercialization plans respecting PEDMARK®
- Prev
- 1
- Next